Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (81-90 of 953) with videos related to

Pageof 96
Sort By:
International Journal of Geriatric Psychiatry|June 22, 2007
Development of quality indicators for memory clinicsIrena Drasković, Myrra Vernooij-Dassen, Frans Verhey, et al.
The Lancet. Neurology|May 24, 2020
Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspectiveGeert Jan Biessels, Flavio Nobili, Charlotte E Teunissen, et al.
Hypertension (Dallas, Tex. : 1979)|May 26, 2004
Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging StudyEsther S C Korf, Lon R White, Philip Scheltens, et al.
International Psychogeriatrics|July 30, 2005
The impact of diagnostic disclosure in dementia: a qualitative case analysisEls Derksen, Myrra Vernooij-Dassen, Freek Gillissen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 18, 2013
An algorithmic approach to structural imaging in dementiaLorna Harper, Frederik Barkhof, Philip Scheltens, et al.
Dementia and Geriatric Cognitive Disorders|April 17, 2004
Validation of the HIV Dementia Scale in an elderly cohort of patients with subcortical cognitive impairment caused by subcortical ischaemic vascular disease or a normal pressure hydrocephalusBarbera van Harten, Marise N J Courant, Philip Scheltens, et al.
Dementia and Geriatric Cognitive Disorders|September 24, 2005
Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?Esther S C Korf, Philip Scheltens, Frederik Barkhof, et al.
Alzheimer'S Research & Therapy|January 27, 2015
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer's disease: an emerging method based upon brain dynamicsElisabeth Cw van Straaten, Philip Scheltens, Alida A Gouw, et al.
The Lancet. Neurology|December 28, 2010
Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 alleleWiesje M van der Flier, Yolande Al Pijnenburg, Nick C Fox, et al.
Journal of Alzheimer'S Disease : JAD|January 25, 2012
Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trialDavid Wilkinson, Nick C Fox, Frederik Barkhof, et al.
Pageof 96

Showing results (81-90 of 953) with videos related to

Sort By:
Pageof 96
International Journal of Geriatric Psychiatry|June 22, 2007
Development of quality indicators for memory clinicsIrena Drasković, Myrra Vernooij-Dassen, Frans Verhey, et al.
The Lancet. Neurology|May 24, 2020
Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspectiveGeert Jan Biessels, Flavio Nobili, Charlotte E Teunissen, et al.
Hypertension (Dallas, Tex. : 1979)|May 26, 2004
Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging StudyEsther S C Korf, Lon R White, Philip Scheltens, et al.
International Psychogeriatrics|July 30, 2005
The impact of diagnostic disclosure in dementia: a qualitative case analysisEls Derksen, Myrra Vernooij-Dassen, Freek Gillissen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 18, 2013
An algorithmic approach to structural imaging in dementiaLorna Harper, Frederik Barkhof, Philip Scheltens, et al.
Dementia and Geriatric Cognitive Disorders|April 17, 2004
Validation of the HIV Dementia Scale in an elderly cohort of patients with subcortical cognitive impairment caused by subcortical ischaemic vascular disease or a normal pressure hydrocephalusBarbera van Harten, Marise N J Courant, Philip Scheltens, et al.
Dementia and Geriatric Cognitive Disorders|September 24, 2005
Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?Esther S C Korf, Philip Scheltens, Frederik Barkhof, et al.
Alzheimer'S Research & Therapy|January 27, 2015
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer's disease: an emerging method based upon brain dynamicsElisabeth Cw van Straaten, Philip Scheltens, Alida A Gouw, et al.
The Lancet. Neurology|December 28, 2010
Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 alleleWiesje M van der Flier, Yolande Al Pijnenburg, Nick C Fox, et al.
Journal of Alzheimer'S Disease : JAD|January 25, 2012
Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trialDavid Wilkinson, Nick C Fox, Frederik Barkhof, et al.
Pageof 96